Virgin Radio Podcast
Ep 150: Spencer Hawkswell – CEO of TheraPsil

It has been a tumultuous year for the world at large, with COVID-19 necessitating sweeping changes to ways of life across nearly every geography and domain. Against this challenging backdrop, psychedelic medicine has gained a great deal of traction in 2020. Research and development—including clinical trials—has continued to gain momentum and maturity, while public opinion, regulatory bodies, and mainstream media outlets all appear to be increasingly amenable to the prospect of psychedelic medicines and therapies.

Learn More

Share this post